💊 Cabergoline

SmartAnswer by DigiNepal SI

Cabergoline is a medication used to treat hyperprolactinemic disorders, which are conditions where the body produces too much prolactin. The safety of Cabergoline Tablets has been studied in over 900 patients, and most side effects are mild or moderate in severity. The most common adverse events during a placebo-controlled study are nausea, headache, and dizziness. Cabergoline is classified as Category B in pregnancy, meaning it is not known to cause harm to the fetus when used during pregnancy. There is limited information available on the effects of Cabergoline on breastfeeding, and it is not known whether the drug is excreted in human milk. Always consult a healthcare provider before starting, stopping, or changing any medication, especially during pregnancy, breastfeeding, in children, or with other medications.

Sources: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

Common side effects

The safety of Cabergoline Tablets has been evaluated in more than 900 patients with hyperprolactinemic disorders. Most adverse events were mild or moderate in severity. The incidence of the most common adverse events during the placebo-controlled study is presented in the following table. Pregnancy (label summary): Teratogenic Effects: Category B. Reproduction studies have been performed with cabergoline in mice, rats, and rabbits administered by gavage. These losses could be due to the prolactin inhibitory properties of cabergoline in rats. Breastfeeding (label summary): Nursing Mothers: It is not known whether this drug is excreted in human milk. General information only, not medical advice and not a prescription. No doses are given. Always consult a doctor or pharmacist before starting, stopping or changing any medicine, especially in pregnancy, breastfeeding, children, older age or with other medicines.